
Three years of scans every three months means finding a way to grow and change that's not limited or defined by cancer

Three years of scans every three months means finding a way to grow and change that's not limited or defined by cancer

Ivosidenib (AG-120) was granted a priority review designation by the Food and Drug Administration (FDA) for the treatment of patients with relapsed/refractory IDH1-mutant acute myeloid leukemia (AML), according to a statement from Agios Pharmaceuticals, the company developing the targeted therapy.

The availability of sexual aids and resources available to cancer survivors at a wide array of cancer centers appeared disappointingly low, according to survey results to be presented at the 2018 Cancer Survivorship Symposium.

Two-time cancer survivor shares the happiness of naptime and her alternatives too. Your body has been through lots and deserves a nap.

For the cancer patient, waiting seems an often too familiar state of being. In this article, one survivor shares her experience with periodic checkups and how they make her feel.

While adolescent and young adult survivors of cancer face an increased risk of long-term complications, many people in this group end up "lost to follow-up," according to recent research.

Should women who are not known to have a hereditary risk for ovarian cancer get screened? The US Preventive Services Task Force says no.

Learning to live with cancer may take a lifetime, but it is time well spent.

Roswell Park Cancer Center researchers shed light on disease incidence among women.

The Food and Drug Administration (FDA) approved Erleada (apalutamide) for the treatment of patients who have nonmetastatic castration-resistant prostate cancer (CRPC). The drug is now the first FDA-approved treatment in this setting.

Yes, I have a great admiration for the Olympic athletes who fall and get right back up. I know they have to wait another four years. But the cancer survivors I have met on my journey who fall and rebound are real heroes to me.

While obesity is a known risk factor for more than a dozen types of cancer – and poised to take over smoking as the leading preventable cause for the disease – it may actually play a beneficial role in men with metastatic melanoma, according to a recent study published in Lancet Oncology.

Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.

After a cancer diagnosis, are we more afraid of our fears of chemo or the chemo itself? This survivor walks through three common chemo fears and what her experiences were like with them.

This breast cancer and melanoma survivor sometimes likes to pretend and ponder about what life would have been if she hadn't gotten cancer.

This HPV-based test can help identify women who are at an increased risk for cervical cancer.

PARP inhibitors have drastically changed the treatment landscape – and outcomes – of patients with ovarian cancer. However, despite promise shown among this class of drugs, it is still unclear which agent is the best to use in the maintenance setting.

Articles posted don't always bring the response we desire. Sometimes, they promote negative feedback.

My wife died on Valentine's Day, and I never thought that the holiday would be the same again.

“Our take home message here is that all women receiving lymph node dissection, whether it is axillary or sentinel, should receive physical therapy to regain range of motion more quickly after surgery, and thus, help maintain physical functioning,” said Electra D. Paskett, Ph.D., MO.

Fatigue is a life-altering and often long-lasting effect that impacts many cancer survivors. And while there is currently no cure for the condition, recent research presented at the 2018 Cancer Survivorship Symposium found that exercise can have both short- and long-term benefits for patients dealing with fatigue.

Lorlatinib was granted a priority review to a new drug application (NDA) for patients with ALK-positive metastatic non–small cell lung cancer (NSCLC) who have progressed on one or more ALK tyrosine kinases inhibitors (TKIs).

People treated for liver cancer at an inner-city hospital experienced better survival odds if they had private health insurance, and also if they were married, according to the results of a recent study that considered how socioeconomic factors affect health outcomes for those with the disease.

The mission of Barbells for Boobs is to mobilize and empower people to take action against breast cancer. The organization will help people – of all ages, and regardless of insurance status or type – to get screened by connecting them with resources in their area.

After losing both my breasts and uterus, I found myself wondering what it means to be a woman.

Yes, some of it is. For years before chemo, I have gone into a room and forgotten why I was there. I have never been good with names, and it has gotten worse. But chemo fog is different.

Medicaid expansion reduced the rate of uninsured patients with testicular cancer, and in particular, enabled more men to have earlier stage diagnoses.

Cancer is a job I never applied for.

Patients with diabetes are at a greater risk for bladder cancer, and worse, for disease recurrence and progression. So, recent research investigated if a certain diet would help.

More than 12 percent of men with prostate cancer tested positive for hereditary mutations of cancer-causing genes, according to study results presented at the 2018 Genitourinary Cancers Symposium.